发布求助
文献互助 智能选刊 最新文献

E-Posters (Trials In Progress)最新文献

筛选
英文 中文
TP007/#1438 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICR: a phase III, randomized controlled clinical trial (debulk trial) 转移性淋巴结手术减体积治疗宫颈癌III期icr的疗效:一项III期随机对照临床试验(减体积试验)
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.516
B. Yun, Kwang-Beom Lee, Keun Ho Lee, H. Chang, J. Kim, M. Lim, C. H. Choi, D. Kim, Y. Kim, Joong-Sub Choi, Chae Hyeong Lee, Jae-Weon Kim, Sang Wun Kim, Yong Bae Kim, C. Cho, D. Hong, Y. Song, Jae-Hoon Kim, K. Eom, J. Roh
{"title":"TP007/#1438 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICR: a phase III, randomized controlled clinical trial (debulk trial)","authors":"B. Yun, Kwang-Beom Lee, Keun Ho Lee, H. Chang, J. Kim, M. Lim, C. H. Choi, D. Kim, Y. Kim, Joong-Sub Choi, Chae Hyeong Lee, Jae-Weon Kim, Sang Wun Kim, Yong Bae Kim, C. Cho, D. Hong, Y. Song, Jae-Hoon Kim, K. Eom, J. Roh","doi":"10.1136/ijgc-2022-igcs.516","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.516","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127540549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP039/#1520 Phase 1B dose-escalation study of ZN-C3 (wee1 inhibitor) with chemotherapy in patients with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: ZN-C3 plus gemcitabine arm 锌- c3 (wee1抑制剂)在铂耐药卵巢癌、腹膜癌或输卵管癌患者化疗中的1B期剂量递增研究:锌- c3加吉西他滨组
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.548
P. Thaker, A. Pašić, G. Richardson, Živko Vranješ, Stanislava Prather, L. Makris, S. Misir, P. Pultar, D. Voliotis, S. Fu
{"title":"TP039/#1520 Phase 1B dose-escalation study of ZN-C3 (wee1 inhibitor) with chemotherapy in patients with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: ZN-C3 plus gemcitabine arm","authors":"P. Thaker, A. Pašić, G. Richardson, Živko Vranješ, Stanislava Prather, L. Makris, S. Misir, P. Pultar, D. Voliotis, S. Fu","doi":"10.1136/ijgc-2022-igcs.548","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.548","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114407041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP038/#1408 Rucaparib maintenance after bevacizumab maintenance following carboplatin based first line chemotherapy in ovarian cancer 基于卡铂的卵巢癌一线化疗后贝伐单抗维持后鲁卡帕尼维持
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.547
J. Dysarz, E. Braicu, K. Pietzner, D. Zocholl, G. Rogmans, P. Wimberger, E. Egger, Jens Gerber, M. Eichbaum, F. Heitz, T. Kupec, Martin Koch, M. Deryal, R. Witteler, A. Sperfeld, O. Tomé, B. Schmalfeldt, F. Marmé, B. Czogalla, J. Sehouli
{"title":"TP038/#1408 Rucaparib maintenance after bevacizumab maintenance following carboplatin based first line chemotherapy in ovarian cancer","authors":"J. Dysarz, E. Braicu, K. Pietzner, D. Zocholl, G. Rogmans, P. Wimberger, E. Egger, Jens Gerber, M. Eichbaum, F. Heitz, T. Kupec, Martin Koch, M. Deryal, R. Witteler, A. Sperfeld, O. Tomé, B. Schmalfeldt, F. Marmé, B. Czogalla, J. Sehouli","doi":"10.1136/ijgc-2022-igcs.547","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.547","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127472203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66) 一项3期、随机、双盲、安慰剂/紫杉醇对照研究:batiraxept联合每周紫杉醇治疗铂耐药复发性卵巢癌患者
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.532
K. Fuh, K. Moore, T. Baert, T. Herzog, D. Cibula, Joyce F. Liu, Laurianne Eberst, S. Lewin, A. Secord, J. Sehouli, T. Myers, A. Bamias, Bj Rimel, N. Colombo, A. Franke, Dipti Shoop, U. Giorgi, J. Pikiel, R. Bowen, A. González-Martín
{"title":"TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66)","authors":"K. Fuh, K. Moore, T. Baert, T. Herzog, D. Cibula, Joyce F. Liu, Laurianne Eberst, S. Lewin, A. Secord, J. Sehouli, T. Myers, A. Bamias, Bj Rimel, N. Colombo, A. Franke, Dipti Shoop, U. Giorgi, J. Pikiel, R. Bowen, A. González-Martín","doi":"10.1136/ijgc-2022-igcs.532","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.532","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116968217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP009/#1444 Compare surgical staging with imaging in locally advanced cervical cancer: a multicenter, phase III trial 比较局部晚期宫颈癌的手术分期与影像学:一项多中心III期试验
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.518
Misi He, Haixia Wang, Mingfang Guo, Ling Wang, Ying Tang, Qi Zhou, D. Zou
{"title":"TP009/#1444 Compare surgical staging with imaging in locally advanced cervical cancer: a multicenter, phase III trial","authors":"Misi He, Haixia Wang, Mingfang Guo, Ling Wang, Ying Tang, Qi Zhou, D. Zou","doi":"10.1136/ijgc-2022-igcs.518","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.518","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115567917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TP024/#446 Upgrade: phase 1 combination trial of the NAPI2B-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UPRI; XMT-1536) in patients with ovarian cancer 升级:napi2b定向抗体药物偶联物(ADC) upifitamab rilsodotin (UPRI;XMT-1536)在卵巢癌患者中的应用
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.533
J. Hays, T. Werner, N. Lakhani, J. Edenfield, J. Buscema, Timothy Burns, Cassandra Carrington, E. Keeton, R. Burger, C. Anderson
{"title":"TP024/#446 Upgrade: phase 1 combination trial of the NAPI2B-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UPRI; XMT-1536) in patients with ovarian cancer","authors":"J. Hays, T. Werner, N. Lakhani, J. Edenfield, J. Buscema, Timothy Burns, Cassandra Carrington, E. Keeton, R. Burger, C. Anderson","doi":"10.1136/ijgc-2022-igcs.533","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.533","url":null,"abstract":"John Hays*, Theresa Werner, Nehal Lakhani, Jeffrey Edenfield, Joseph Buscema, Timothy Burns, Cassandra Carrington, Erika Keeton, Robert Burger, Charles Anderson. Ohio State University James Cancer Center, Medical Oncology, Columbus, USA; Huntsman Cancer Institute, Medical Oncology, Salt Lake City, USA; Cancer and Hematology Centers of Western Michigan, Medical Oncology, Grand Rapids, USA; Greenville Hospital System University Medical Center, University of South Carolina, Medical Oncology, Greenville, USA; Arizona Oncology Associates, Gynecologic Oncology, Tucson, USA; University of Pittsburgh, Medical Oncology, Pittsburgh, USA; Mersana Therapeutics, Clinical Trial Manager, Cambridge, USA; Mersana Therapeutics, Clinical Research, Cambridge, USA; Mersana Therapeutics, Clinical Development, Cambridge, USA; Willamette Valley Cancer Institute and Research Center, Medical Oncology, Eugene, USA","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124950184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TP010/#242 AFT-50 EndoMAP: a phase IB/II multicohort study of targeted agents with atezolizumab (ATEZO) for patients (PTS) with recurrent or persistent endometrial cancer (EC) AFT-50 EndoMAP:针对复发或持续性子宫内膜癌(EC)患者(PTS)的atezolizumab (ATEZO)靶向药物的IB/II期多队列研究
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.519
E. Cantillo, T. Zemla, J. Moroney, Edwin Alvarez, Lauren E. Yauch, Yvonne Lin, Michelle Brockman, Gilllian Dilallo, Joyce F. Liu, A. Secord, A. Nixon, S. Mandrekar, U. Matulonis, D. Kozono, B. Slomovitz
{"title":"TP010/#242 AFT-50 EndoMAP: a phase IB/II multicohort study of targeted agents with atezolizumab (ATEZO) for patients (PTS) with recurrent or persistent endometrial cancer (EC)","authors":"E. Cantillo, T. Zemla, J. Moroney, Edwin Alvarez, Lauren E. Yauch, Yvonne Lin, Michelle Brockman, Gilllian Dilallo, Joyce F. Liu, A. Secord, A. Nixon, S. Mandrekar, U. Matulonis, D. Kozono, B. Slomovitz","doi":"10.1136/ijgc-2022-igcs.519","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.519","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134220191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP034/#1534 Randomized phase III trial on niraparib-TSR-042 (Dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, primary peritoneal cancer platinum resistant patients: nitche trial(MITO 33) niaparib - tsr -042 (Dostarlimab)与医生选择化疗在复发性卵巢癌、输卵管癌、原发性腹膜癌铂耐药患者中的随机III期试验:nitche试验(MITO 33)
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.543
V. Salutari, L. Musacchio, S. Pignata, E. Braicu, D. Cibula, N. Colombo, J. Frenel, F. Zagouri, Floriana Camarda, S. Giolitto, E. Giudice, M. Perri, G. Scambia, D. Lorusso
{"title":"TP034/#1534 Randomized phase III trial on niraparib-TSR-042 (Dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, primary peritoneal cancer platinum resistant patients: nitche trial(MITO 33)","authors":"V. Salutari, L. Musacchio, S. Pignata, E. Braicu, D. Cibula, N. Colombo, J. Frenel, F. Zagouri, Floriana Camarda, S. Giolitto, E. Giudice, M. Perri, G. Scambia, D. Lorusso","doi":"10.1136/ijgc-2022-igcs.543","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.543","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"118 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128165135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP005/#272 Contessa/neocon-F trial: neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer TP005/#272 Contessa/neocon-F试验:FIGO 2018年IB2期宫颈癌的新辅助化疗后保留生育能力的手术
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.514
M. Plante, Nienke van Trommel, Mirte Schaafsma, A. Oza, Angela Rodriguez, Lisa Wang, K. Sikorska, Sarah Ferguson, K. Han, S. Lheureux, F. Amant
{"title":"TP005/#272 Contessa/neocon-F trial: neoadjuvant chemotherapy followed by fertility-sparing surgery in FIGO 2018 stage IB2 cervical cancer","authors":"M. Plante, Nienke van Trommel, Mirte Schaafsma, A. Oza, Angela Rodriguez, Lisa Wang, K. Sikorska, Sarah Ferguson, K. Han, S. Lheureux, F. Amant","doi":"10.1136/ijgc-2022-igcs.514","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.514","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128201141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP019/#1556 PICCOLO: an open-label, single arm, phase 2 study of mirvetuximab soravtansine in recurrent platinum sensitive, high-grade epithelial ovarian cancers with high folate-alpha expression PICCOLO:一项开放标签、单组、2期研究，mirvetuximab soravtansine治疗复发性铂敏感、高叶酸- α表达的高级别上皮性卵巢癌
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.528
A. Secord, S. Lewin, M. Method, C. Murphy
{"title":"TP019/#1556 PICCOLO: an open-label, single arm, phase 2 study of mirvetuximab soravtansine in recurrent platinum sensitive, high-grade epithelial ovarian cancers with high folate-alpha expression","authors":"A. Secord, S. Lewin, M. Method, C. Murphy","doi":"10.1136/ijgc-2022-igcs.528","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.528","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"22 18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123423254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书